CLINICAL-FEATURES OF MDS

被引:27
作者
HAMBLIN, T
机构
[1] Royal Victoria Hospital, Bournemouth, Shelley Road
关键词
MYELODYSPLASTIC SYNDROME; ACUTE LEUKEMIA;
D O I
10.1016/0145-2126(92)90106-H
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MDS is primarily a disease of the elderly. Cases who give a history of exposure to X-rays, cytotoxic drugs or leukaemogenic chemicals may be younger. Many cases of MDS present because of an incidental blood count. The most prominent clinical features are those of anaemia, neutropenia, thrombocytopenia. Because haemopoietic tissue is also dysfunctional the pathological effect is often greater than the figures would suggest, even leading to infection of bleeding with normal neutrophil or platelet counts. Occult abscesses are a particular feature. Despite documented abnormalities of the lymphoid system, neither infections characteristic of T-cell immunodeficiency nor autoimmunity is a problem. The proliferation of monocytes in CMML leads to organomegaly, leukaemia cutis, serous effusions and vasculitic lesions caused by the mishandling of circulating immune complexes. Cancer is no commoner than in age-matched controls, but coincident lymphoid tumours do occur. Many patients require long-term blood transfusion and will run into problems of iron overload unless precautions are taken.
引用
收藏
页码:89 / 93
页数:5
相关论文
共 49 条
[1]   ACQUIRED HEMOGLOBIN-H DISEASE IN A CASE OF REFRACTORY-ANEMIA WITH EXCESS OF BLASTS (RAEB) EVOLVING INTO ACUTE NONLYMPHOID LEUKEMIA [J].
ANNINO, L ;
DIGIOVANNI, S ;
TENTORI, L ;
CAFOLLA, A ;
COSTA, MPN ;
SALVAGNINI, ML ;
ANGELI, G .
ACTA HAEMATOLOGICA, 1984, 72 (01) :41-44
[2]   GLUCOCORTICOID THERAPY IN THE PRELEUKEMIC SYNDROME (HEMATOPOIETIC, DYSPLASIA) - IDENTIFICATION OF RESPONSIVE PATIENTS USING INVITRO TECHNIQUES [J].
BAGBY, GC ;
GABOUREL, JD ;
LINMAN, JW .
ANNALS OF INTERNAL MEDICINE, 1980, 92 (01) :55-58
[3]  
BILLSTROM R, 1990, EUR J HAEMATOL, V45, P150
[4]   BLOOD NEUTROPHIL FUNCTION IN PRIMARY MYELODYSPLASTIC SYNDROMES [J].
BOOGAERTS, MA ;
NELISSEN, V ;
ROELANT, C ;
GOOSSENS, W .
BRITISH JOURNAL OF HAEMATOLOGY, 1983, 55 (02) :217-227
[5]   GLOBIN CHAIN SYNTHESIS IN MYELODYSPLASTIC SYNDROMES [J].
CHALEVELAKIS, G ;
KARAOULIS, S ;
YALOURIS, AG ;
ECONOMOPOULOS, T ;
TOUNTAS, N ;
RAPTIS, S .
JOURNAL OF CLINICAL PATHOLOGY, 1991, 44 (02) :134-138
[6]   DANAZOL THERAPY IN MYELODYSPLASIA [J].
CINES, DB ;
CASSILETH, PA ;
KISS, JE .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (01) :58-60
[7]   GRANULOCYTE AND MONOCYTE SURFACE-MEMBRANE MARKERS IN THE MYELODYSPLASTIC SYNDROMES [J].
CLARK, RE ;
HOY, TG ;
JACOBS, A .
JOURNAL OF CLINICAL PATHOLOGY, 1985, 38 (03) :301-304
[8]  
COOPER PH, 1983, CANCER-AM CANCER SOC, V51, P1518, DOI 10.1002/1097-0142(19830415)51:8<1518::AID-CNCR2820510827>3.0.CO
[9]  
2-U
[10]  
COPPLESTONE JA, 1986, CLIN LAB HAEMATOL, V8, P115, DOI 10.1111/j.1365-2257.1986.tb00086.x